The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Think so, Masks, complete with a few devoted 'disciples' all out for a good day's agenda.
Depends on the thesaurus used, but unsurprisingly some have 'pseudonym' as a synonym for 'disciple'.
I 'mostly' describe one mistake out of one hundred as 'always', it's all very similar from a distance as I'm tucking in to my imaginary picnic.
Then I wake up. Still, it's good to dream. ;o)
Sure you've got that 99 out of 100 ratio correct KD ? Use of the word 'always' in a 'previous'.
_____
KD37
Posted in: DDDD
Posts: 272
Price: 92.20
Strong Buy
RE: interesting read
04 Dec 2020 22:36
Worst timing ever?
How do I always buy at £1.20 and sell at 86p with these?
Regardless of the reason.
It just demonstrates that the price can rise dramatically given the right conditions, the same for any stock.
Xenor
I'm not suggesting I agree with another posters price predictions up or down but it isn't 'a ramp' to suggest that such price movements can happen. This stock has 'form' for doing just that.
They did a placing in June 2014 at £1.50 a share and the price shot up from £2 to £10 in twelve months.
Nothng to stop similar price behaviours repeating with the right news and that applies to any stock.
The potential market.
'It is estimated 322 million men worldwide will be affected by 2025'
Fag packet thoughts:
Make it 100 million men happy to spend £10 a month.
£12 Billion annual market.
Well, it may be considered unjust to assume that 1Haberdasher is a wolf in sheep's clothing, and I thought it only fair to give the benefit of the doubt by doing as he suggested and check the posting history.
Having now completed that arduous task, and accepting without umbrage that it's a whole three minutes that I'll never get back, I am pleased to provide a brief synopsis. I don't for one moment believe that 1Haberdasher is 'a wolf in sheep's clothing'.
More akin to 'a troll in men's clothing'.
Iron
Sparkz can't read, bless. There was nothing negative about COPL at all, it's just a personal rule, if ever I get a choice, I won't opt for suspension and I know I'll lose out by it but those are the rules for me, set by me. You'll do well here on re-list, which is what I also wrote in the previous post.
Myles McNulty
@MylesMcNulty
·
4m
A real step change for ?#MOS? today, with its largest contract to date. Annual run-rate for the nascent Streams platform up to £0.3m now, just in the UK.
My hope is that the new China partnership will put these numbers to shame in due course.
The below table shows just how highly rated SaaS businesses can be by the market. It is evident that ?#MOS? could command a valuation of at least 2-3x its current mkt cap, just on the current rev run-rate.
I hold purely for the new start-up side of the biz; but it's nevertheless pleasing to see that today's new partnership believes it can "generate significant potential additional revenue from the ?#MOS? legacy business."
Cash in hand will see the Co through to YE - and there's still ~£0.27m in warrant monies to come at 0.20p, and a further ~1.63m at 0.50p.
Some will probably have guessed but cashed in on Tuesday.
Nothing negative for the reason at all and I'm confident you'll all do brilliantly when it re-lists. I just have a hang up about not being able to access an asset, and I'm reminded of my Dad's hang up of not answering the door until he'd put a suit on, 'on principle', by the time he got there, they'd gone ! Similar type of 'principle' as mine. :o)
Had a quick read through and your post Base, as a response to Bobs, I'm still laughing.
_______
panamabob
RE: St patsWed 16:45
Happy Paddy's Day to you Clockface
_______
baserite
RE: St pats 16:50
Glad you managed to spell that one correctly Bob lol
_______
Brilliant !
Anyway, enjoy your re-list and Hoping, don't forget the analogy, 'a rusty gate keeps swinging'. :o)
'Stupid' is when your ego forces you to try to talk down or rubbish the very things you chose to spend your cash on, such as your own investments, just to appear 'to be right' to a bunch of completely anonymous strangers who really don't give a t.o.s.s. either way.
If the cap fits ....
“Our plans to launch the EpiSwitch® Covid-19 Severity Test (CST) based on this groundbreaking biomarker discovery work by the end of Q1 2021, are on track."
Depends how literal the words are taken. 'By the end of' suggests 'latest' end of March but could be before. 'Are on track' .... so, that's any day from now up to a max of nine trading days.
Pict
Not really.
18 Billion in PREM. Didn't stop it 8 bagging.
Thanks, you too.
'Yet'
Can't answer that one.
How do you know they won't increase it again ?
You can't answer that one either.
Two sides to every consideration.
So, 18%, £3 .1 Million, and plenty of skin in the game :o)
Fast
Just another observation.
That's exactly the type of post being printed at PREM a few weeks ago at the start of it's rerate and much more besides, with greater levels of dissatisfaction than anything you've raised and from hundreds of posters.
Past performance is not a guarantee of future performance, good or bad. External influences, such as demand for an underlying resources, have far greater influence than a few unhappy or happy posters.
Anyway, the price action will dictate the outcome, it doesn't matter what you or I write with individual opinions. There are over 2.2 million PI's, with £60 Billion to play with in Stocks and Shares ISA's alone.
Fair enough Daz
With £3.5 Million skin in the game, he's more aligned than most to want to get the agreement in place once the licence is granted.
Thanks Daz
The interest for me was more about the location and positioning of Suay Chin and the relationship with the relevant Chinese sectors, than it was about the % Holding.
Suay Chin is a Singapore-based company
that was formed to take advantage of its extensive contacts throughout the Chinese chemical industry and to operate as a trading company
for the supply of materials to the Chinese industry.
Following a subscription of shares in May 2017 and June 2018, Suay Chin holds 2,227,971,568 Kodal shares, equating to
29.02% of the total issued share capital of the Company.
Suay Chin is involved in all levels of the lithium market from supplying material to acid producers, supplying spodumene concentrate and lithium hydroxide to the Chinese lithium carbonate producers,
to the final end-user chemical and battery manufacturers.
The company gets strong support from Shandong Mingrui Chemical Co Ltd, which is a long-term material supplier to existing lithium carbonate producers in Shandong Province and has deep understanding about the Chinese lithium market.
Suay Chin arranged the metallurgical testing of Kodal’s spodumene rich pegmatite samples by existing lithium carbonate producers in China and is expected to continue to offer strong technical contribution to the development of the Project.